Professor, Psychiatry, Washington University School of Medicine
Psychiatry
Dr. Eric J. Lenze, MD
|
|
Give Review
Eric J. Lenze practices Psychiatry. He went to Washington University School of Medicine in St. Louis. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Eric Lenze is a published doctor. He published 100 publications, including: 'Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.' Eric J. Lenze, MD accepts all Medicare patients.
Publications
- Ecological momentary assessment versus standard assessment instruments for measuring mindfulness, depressed mood, and Anxiety among older adults.
- Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
- Trajectories of suicidal ideation in depressed older adults undergoing antidepressant treatment.
- Getting to More Effective Weight Management in Antipsychotic-Treated Youth: A Survey of Barriers and Preferences.
- Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial.
- Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults.
- Depression Remission Rates Among Older Black and White Adults: Analyses From the IRL-GREY Trial.
- Response to mohler and colleagues.
- Ecological Momentary Assessment of Tinnitus Using Smartphone Technology: A Pilot Study.
- Effects of Mindfulness Based Stress Reduction Therapy on Subjective Bother and Neural Connectivity in Chronic Tinnitus.
- Short-term affective recovery from hip fracture prospectively predicts depression and physical functioning.
- Cause or Effect? Selective Serotonin Reuptake Inhibitors and Falls in Older Adults: A Systematic Review.
- A Novel Treatment for Tinnitus and Tinnitus-Related Cognitive Difficulties Using Computer-Based Cognitive Training and D-Cycloserine.
- Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults.
- Depression, Antidepressants, and Bone Health in Older Adults: A Systematic Review.
- Patient Active Time During Therapy Sessions in Postacute Rehabilitation: Development and Validation of a New Measure.
- Combining D-Cycloserine with motor training does not result in improved general motor learning in neurologically-intact people or in people with stroke.
- Antiglucocorticoid therapy for older adults with Anxiety and co-occurring cognitive dysfunction: results from a pilot study with mifepristone.
- Mindfulness-based stress reduction for older adults with worry symptoms and co-occurring cognitive dysfunction.
- Validation of the Ambivalent and Purposeful Engagement - Trait Measure.
- Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults.
- Common Selective Serotonin Reuptake Inhibitor Side Effects in Older Adults Associated with Genetic Polymorphisms in the Serotonin Transporter and Receptors: Data from ...
- Lessons learned from D-cycloserine: the promise and limits of drug facilitation of exposure therapy.
- Escitalopram reduces attentional performance in anxious older adults with high-expression genetic variants at serotonin 2A and 1B receptors.
- Enhanced medical rehabilitation is feasible in a skilled nursing facility: preliminary data on a novel treatment for older adults with depression.
- Dynamic Prediction of Treatment Response in Late-Life Depression.
- Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.
- Association of cortisol with neuropsychological assessment in older adults with generalized Anxiety disorder.
- A HIGH-THROUGHPUT CLINICAL ASSAY FOR TESTING DRUG FACILITATION OF EXPOSURE THERAPY.
- Memantine for late-life depression and apathy after a disabling medical event: a 12-week, double-blind placebo-controlled pilot study.
- Inflammatory cytokine levels and Depressive symptoms in older women in the year after hip fracture: findings from the Baltimore hip studies.
- Improving recognition of late life Anxiety disorders in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition: observations and recommendations of the A...
- Changes in neuropsychological functioning following treatment for late-life generalised Anxiety disorder.
- Treatment-related alteration of cortisol predicts change in neuropsychological function during acute treatment of late-life Anxiety disorder.
- Elevated cortisol in older adults with generalized Anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram.
- Anxiety disorders: new developments in old age.
- Treating depression in older adults with dementia.
- Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidep...
- Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized Anxiety disorder in older adults.
- Augmenting antidepressant medication with modular CBT for geriatric generalized Anxiety disorder: a pilot study.
- Anxiety disorders in older adults: a comprehensive review.
- Cognitive and affective predictors of rehabilitation participation after stroke.
- The burden of late-life generalized Anxiety disorder: effects on disability, health-related quality of life, and healthcare utilization.
- Patient participation and physical activity during rehabilitation and future functional outcomes in patients after hip fracture.
- Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients.
- Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
- Escitalopram for older adults with generalized Anxiety disorder: a randomized controlled trial.
- The utility of the Generalized Anxiety Disorder Severity Scale (GADSS) with older adults in primary care.
- High worry severity is associated with poorer acute and maintenance efficacy of antidepressants in late-life depression.
- Apathy after hip fracture: a potential target for intervention to improve functional outcomes.
- Generalized Anxiety disorder severity scale validation in older adults.
- Do clinical rehabilitation education programs really improve stroke-related knowledge?
- Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability.
- Biomarkers in geriatric psychiatry.
- Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy.
- Stroke-related knowledge and health behaviors among poststroke patients in inpatient rehabilitation.
- Cognitive impairment in late-life generalized Anxiety disorder.
- Preventing depression in medical illness: a new lead?
- Recovery from Major depression in older adults receiving augmentation of antidepressant pharmacotherapy.
- Does depression, apathy or cognitive impairment reduce the benefit of inpatient rehabilitation facilities for elderly hip fracture patients?
- Onset of depression in elderly persons after hip fracture: implications for prevention and early intervention of late-life depression.
- Impact of prior treatment exposure on response to antidepressant treatment in late life.
- Influence of rehabilitation site on hip fracture recovery in community-dwelling subjects at 6-month follow-up.
- Outcomes of late-life Anxiety disorders during 32 weeks of citalopram treatment.
- Evidence-based treatment of geriatric Anxiety disorders.
- Predictors of adequacy of depression management in the primary care setting.
- Somatic symptoms in late-life Anxiety: treatment issues.
- Association of the serotonin transporter gene-linked polymorphic region (5-HTTLPR) genotype with depression in elderly persons after hip fracture.
- The course of functional decline in older people with persistently elevated Depressive symptoms: longitudinal findings from the Cardiovascular Health Study.
- Effect of rehabilitation site on functional recovery after hip fracture.
- Efficacy and tolerability of citalopram in the treatment of late-life Anxiety disorders: results from an 8-week randomized, placebo-controlled trial.
- Generalized Anxiety disorder in late life: lifetime course and comorbidity with major depressive disorder.
- Significance of poor patient participation in physical and occupational therapy for functional outcome and length of stay.
- The Pittsburgh Rehabilitation Participation Scale: reliability and validity of a clinician-rated measure of participation in acute rehabilitation.
- Treatment considerations for Anxiety in the elderly.
- Achieving long-term optimal outcomes in geriatric depression and Anxiety.
- Comorbidity of depression and Anxiety in the elderly.
- Risk factors for falls during treatment of late-life depression.
- Effect of cerebrovascular risk factors on depression treatment outcome in later life.
- Combined pharmacotherapy and psychotherapy as maintenance treatment for late-life depression: effects on social adjustment.
- Physician office visits of adults for Anxiety disorders in the United States, 1985-1998.
- Clinically relevant behaviors in elderly hip fracture inpatients.
- Association of functional polymorphisms from brain-derived neurotrophic factor and serotonin-related genes with Depressive symptoms after a medical stressor in older a...
- Subjective health measures and acute treatment outcomes in geriatric depression.
- Comorbidity of depression and Anxiety disorders in later life.
- The association of late-life depression and Anxiety with physical disability: a review of the literature and prospectus for future research.
- Comorbid Anxiety disorders in depressed elderly patients.
- Absence of striatal volume differences between depressed subjects with no comorbid medical illness and matched comparison subjects.
- White matter hyperintensities and gray matter lesions in physically healthy depressed subjects.
- Psychiatric symptoms endorsed by somatization Disorder patients in a psychiatric clinic.
- Reactivation of latent herpes simplex virus by excimer laser photokeratectomy.
- Anxiety symptoms in elderly patients with depression: what is the best approach to treatment?
- Good treatment outcomes in late-life depression with comorbid Anxiety.
- Anxiety disorders in late life: an evolving picture.
- Somatic symptoms of depression in elderly patients with medical comorbidities.
- Comorbid Anxiety disorder in late life depression: association with memory decline over four years.
- Time course of response to antidepressants in late-life Major depression: therapeutic implications.
- Adverse effects of depression and cognitive impairment on rehabilitation participation and recovery from hip fracture.
- Maintenance treatment of Major depression in old age.
Schools
Washington University In St Louis School Of Medicine
Procedures Preformed
- Electroconvulsive Therapy (ECT)
- Psychiatric Evaluation
Conditions Treated
- Anxiety
- Bipolar Disorder
- Major Depressive Disorder
- Phobia
- View All
Doctors Specialties
- Geriatric Psychiatry
- Psychiatry
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- HealthLink PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pittsburgh Medical Center -
Washington University -
Washington University School of Medicine in St. Louis
Hospital
-
Barnes-Jewish Hospital
Drug Facts
| NPI NUMBER | 1619941846 | |
| NPPES Provider LastName | LENZE | |
| NPPES Provider FirstName | ERIC | |
| NPPES Provider ZIPCode | 631081301 | |
| NPPES Provider State | MO | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 1263.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 1.43 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1619941846 |
| Last Name Of The Provider | LENZE |
| First Name Of The Provider | ERIC |
| View All |
Similar Doctors
|
|
Dr. Vadim Y. Baram, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abhilash K. Desai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward G. Dewein Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arshad Bhatt, MD |
|
|
Dr. George I. Viamontes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharmistha Barai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William M. Irvin Jr., MD |
|
|
Dr. Wedward Turner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Morgan E. White, MD |